Bladder cancer — all decisions

The Board remanded the claims for service connection for bladder cancer, lung cancer, and kidney cancer. The Veteran's exposure to Agent Orange in Okinawa is being reviewed.

The Board denied service connection for diabetes, bladder cancer, hypertension, bronchitis, and asthma due to lack of evidence linking these conditions to the veteran's military service.

The veteran is granted a 20% rating for bladder cancer residuals starting from December 5, 2022. Service connection for peripheral neuropathy in all extremities was denied.

The appeal for special monthly compensation based on the loss of use of a creative organ was dismissed because the rating decision implemented a previous Board decision and was not appealable.

The appeals for service connection of colon cancer, coronary artery disease, diabetes, gall bladder cancer, and pancreatic cancer were dismissed without prejudice due to the veteran's death.

The veteran's claim for an earlier effective date for bladder cancer service connection was denied. The claim for a higher rating is being sent back for more evidence.

The appeal to reduce the veteran's bladder cancer rating from 60% to 40% was dismissed because no actual reduction had occurred, making the appeal premature.

The appeal for service connection of bladder cancer was dismissed because the veteran withdrew the appeal.

The Board remanded the veteran's claims for service connection for prostate cancer, bladder cancer, and erectile dysfunction. The Board found errors in VA's duty to assist the veteran.

The Board denied the veteran's request to reopen his claim for service connection of bladder cancer due to herbicide exposure because no new and relevant evidence was submitted.

The Board granted service connection for bladder cancer and remanded claims for a urinary disorder and erectile dysfunction, while denying prostate cancer.

The Board denied the veteran's request for an earlier effective date for service connection of bladder cancer. The effective date remains August 10, 2022.

The Board remanded the claims for service connection for prostate cancer and bladder cancer. The Veteran's exposure to herbicides at Fort Knox during his service will be investigated.

The Board denied the veteran's request for an earlier effective date for service connection of bladder cancer. The effective date remains June 25, 2012.

The Board remanded the Veteran's claims for service connection for bladder cancer, hypertension, and melanoma. The Veteran alleges these conditions are related to chemical/toxic exposures during his service.

The Board denied the Veteran's request for an effective date earlier than November 3, 2021, for service connection of residuals of bladder cancer. The earliest possible effective date as a matter of law is November 3, 2021.

The Board granted eligibility for direct payment of attorney fees from past due benefits awarded in a February 2023 rating decision granting service connection for bladder and abdominal cancers.

The veteran's service connection for bladder cancer, diabetes mellitus type II, and ischemic heart disease due to herbicide exposure is granted.

The Board dismissed the veteran's appeals for earlier effective dates related to bladder cancer and erectile dysfunction due to untimely filing.

The Board remanded the veteran's claims for service connection for abdominal pain, bladder cancer and residuals, GERD, and erectile dysfunction. The Board found that the VA examinations were inadequate and ordered new examinations to determine the etiology of these conditions.